Free Trial

Microbix Biosystems (TSE:MBX) Reaches New 1-Year High - Here's Why

Microbix Biosystems logo with Medical background

Microbix Biosystems Inc. (TSE:MBX - Get Free Report) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as C$0.50 and last traded at C$0.50, with a volume of 1457199 shares trading hands. The stock had previously closed at C$0.44.

Microbix Biosystems Trading Up 19.5 %

The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. The company has a market cap of C$71.08 million, a price-to-earnings ratio of 13.00 and a beta of 0.34. The business has a fifty day simple moving average of C$0.37 and a 200 day simple moving average of C$0.35.

Microbix Biosystems Company Profile

(Get Free Report)

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Microbix Biosystems Right Now?

Before you consider Microbix Biosystems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbix Biosystems wasn't on the list.

While Microbix Biosystems currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines